MedPath

Gunkang Pharmaceuticals, Inc

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy

Phase 3
Completed
Conditions
Colonoscopy
Bowel Preparation
Interventions
First Posted Date
2024-03-19
Last Posted Date
2025-02-19
Lead Sponsor
Gunkang Pharmaceuticals, Inc
Target Recruit Count
318
Registration Number
NCT06317350
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath